You Searched
₹5,299


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Ovarian cancer : Ovarian cancer is a cancer that begins in the female organs that produce eggs (ovaries). This type of cancer is usually detected very late and can be fatal too. It usually spreads to the pelvis and stomach. Admatop 2.5 Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but has some side effects that may be bothersome. Consult your doctor to know about ways that can help you avoid these side effects.
Side effects of Admatop Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Admatop Tiredness Vomiting Weakness Nausea Abdominal pain Indigestion Decreased white blood cell count Decreased blood cells (red cells, white cells, and platelets)Diarrhea Injection site reactions (pain, swelling, redness)
How to use Admatop Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Admatop Injection works Admatop 2.5 Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase I) involved in DNA multiplication of the cancer cells. This slows the growth of cancer cells and eventually kills them.
Safe: No harmful side effects are associated with consuming alcohol alongside Admatop 2.5 Injection
Admatop 2.5 Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Admatop 2.5 Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Admatop 2.5 Injection may cause side effects which could affect your ability to drive.Admatop 2.5 Injection can make you feel tired and this may affect your ability to drive.
Admatop 2.5 Injection should be used with caution in patients with kidney disease. Dose adjustment of Admatop 2.5 Injection may be needed. Doctor consultation is advised.Use of Admatop 2.5 Injection is not recommended in patients with end-stage kidney disease.
Admatop 2.5 Injection is safe to use in patients with liver disease. No dose adjustment of Admatop 2.5 Injection is recommended.
If a dose of Admatop 2.5 Injection is missed, it's advisable to consult your doctor.
SCO 84, Sector 5, Panchkula (Haryana), 134112 INDIA.
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1711-12
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 951
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1383
Topotecan hydrochloride. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 1996 (24 Jan. 2019)
Topotecan. Unterach, Austria: Ebewe Pharma; 1996 (27 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
Drugs and Lactation Database (LactMed) (19 Feb. 2020)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.